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Abstract
Background: The objective is to present the design of randomised clinical trial (RCT) on the
effectiveness of physical therapy added to general practitioners management compared to general
practitioners management only in patients with an acute lumbosacral radicular syndrome (also
called sciatica).
Methods/Design:  Patients in general practice diagnosed with an acute (less than 6 weeks)
lumbosacral radicular syndrome and an age above 18 years are eligible for participation. The general
practitioners treatment follows their clinical guideline. The physical therapy treatment will consist
of patient education and exercise therapy. The primary outcome measure is patients reported
global perceived effect. Secondary outcome measures are severity of complaints, functional status,
health status, fear of movement, medical consumption, sickness absence, costs and treatment
preference. The follow-up is 52 weeks.
Discussion:  Treatment by general practitioners and physical therapists in this study will be
transparent and not a complete "black box". The results of this trial will contribute to the decision
of the general practitioner regarding referral to physical therapy in patients with an acute
lumbosacral radicular syndrome.
Background
Why a design article?
Publishing the design of the trial has several advantages. It
may prevent publication bias [1]. A study producing pos-
itive results seems more likely to be published than a
study that reports no or negative results [2,3]. Also, the
study can be included in systematic reviews because data
can be retrieved from the researcher [2]. Publishing the
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design of a study before the results are available provides
an opportunity to reflect critically on the design of the
study, irrespective of the results. Also, a design article pro-
vides detailed information about the intervention within
the trial to care givers.
The lumbosacral radicular syndrome (LRS) is a complex
of symptoms related to the lumbosacral nerve roots. The
LRS is a disorder with radiating pain in the leg below the
knee in one or more lumbar or sacral dermatomes, and
can be accompanied by phenomena associated with nerve
root tension or neurological deficits (i.e. sensory deficits
in the leg, decreased muscle strength in the leg, decreased
reflexes, urinary problems) [4-7]. A prolapsed disc is a fre-
quent cause of LRS, but other causes include spinal or lat-
eral recess stenosis, tumours and radiculitis [4,5,7,8]. The
incidence of LRS in the Netherlands is estimated at 5 per
1000 persons a year [8].
Most patients seeking medical care in the Netherlands will
first visit a general practitioner (GP), who is regarded as
the 'gatekeeper' of the health care system. The majority of
health problems presented to GPs are treated by the GPs
themselves and they are responsible for most referrals to
(para) medical specialists. In 1996 the Dutch College of
General Practitioners published their clinical guideline for
LRS [5]. There is consensus that treatment of LRS in the
first six to eight weeks should be conservative. The exact
content of the conservative treatment is yet not clear [9].
Since the study of Vroomen et al. [10] bed rest is not
regarded a treatment option for LRS anymore.
Primarily, treatment consists of adequate pain medica-
tion, giving information about the natural course of LRS,
which in general is favourable, and stimulating to con-
tinue the normal daily activities of the patient. GPs in the
Netherlands largely comply with the recommendations
stated in the clinical guideline regarding management in
patients with LRS [11]. However, they deviated regarding
the referral to physical therapy (PT), almost half of
patients with LRS were referred, whereas this was not rec-
ommended in the guideline. No specific patients charac-
teristics could be found for the prescription of physical
therapy. So, in general practice referral to PT in patients
with LRS is common. However, there is a lack of knowl-
edge of the effectiveness of PT in LRS. Therefore, the aim
of this article is to present the design of a randomised clin-
ical trial of conservative treatment (general practitioners
and physical therapy) in patients with acute LRS.
Methods/Design
Aim
The LRS trial aims to assess the effectiveness of PTs man-
agement added to GPs management compared to GPs
management only in patients with acute LRS. We will use
a multicentre, randomised clinical trial as study design.
Figure 1 shows the flow chart of the proposed design of
the LRS trial. The procedures and design of this study are
approved by the Erasmus Medical Center Ethics
Committee.
Study population
Participating GPs in and around Rotterdam, the Nether-
lands, will invite patients with suspected acute LRS to par-
ticipate in the trial. GPs will invite patients from May
2003 till November 2004 if they have radiating (pain)
complaints in the leg below the knee; duration of the
(pain)complaints is less than 6 weeks, the age is above 18
years and they present one of the following symptoms:
more pain on coughing, sneezing or straining, decreased
muscle strength in the leg, sensory deficits in the leg,
decreased reflex activity in the leg or a positive straight leg
raising test. Patients will receive a letter of information
about the LRS trial from their GP. Patients' name and tel-
ephone number will be faxed to the research institute.
Subsequently, a researcher (PL) will screen eligible
patients by telephone and make an appointment to check
inclusion and exclusion criteria, to complete the informed
consent procedure and to perform the baseline measure-
ment. Figure 2 shows the criteria that must be fulfilled to
participate in the LRS trial. A research assistant will check
these criteria during patients first visit. The informed con-
sent procedure is completed when patients meet the crite-
ria, are willing to participate and give their written
consent. Hereafter, the baseline measurement will take
place.
Randomisation
Randomisation will take place after baseline measure-
ment by the research assistant. We use a concealed ran-
domisation procedure using a computer generated
randomisation list developed by an independent person.
Patients' specific and unique trial number will be typed in
a special developed database (i.e. not editable for research
assistant and a second randomisation action using the
same trial number is not possible) and the random allo-
cation will appear on screen. In order to prevent unequal
treatment group sizes, block randomisation will be used
with blocks of 10 patients [12]. This means that after every
10th patient the number of patients allocated to both
treatment groups is equal. Towards every randomised
patient will be explained that the management of their
complaint by his or her GP will be continued. Patients
who are allocated to physical therapy will be shown a list
of participating physical therapists of which he or she can
make a choice. The research assistant makes the first
appointment with the physical therapist most easily acces-
sible by the patient.BMC Musculoskeletal Disorders 2004, 5:39 http://www.biomedcentral.com/1471-2474/5/39
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Flow chart of the LRS trial Figure 1
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Blinding
For obvious reasons GPs and PTs are not blinded for treat-
ment allocation. But they are not involved with treatment
effect measurements. The patients cannot be blinded
because of the ethical reasons as stated by the Medical Eth-
ical Committee. The researcher is involved in the statisti-
cal analysis, but the analysis and interpretation of the
findings will be audited and verified by an independent
and not involved statistician. In this trial the primary out-
come measurement and most of the secondary outcome
measurements will be scored by the patients. Studies from
Ostelo et al [13] and Scholten-Peeters et al [14] men-
tioned that in this type of study patients are blinded to a
certain extent because they are unaware of the exact con-
tent of both treatments or may be called naive to the con-
tent of the treatment not received. Other more or less
Selection criteria for trial eligibility Figure 2
Selection criteria for trial eligibility.BMC Musculoskeletal Disorders 2004, 5:39 http://www.biomedcentral.com/1471-2474/5/39
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similar designed trials from Vroomen et al [10] and Hofs-
tee et al [15] reported that it is not possible to blind
participating patients for allocated treatment. Therefore,
we think it is important to know any treatment preference
of the patients at baseline. Supplementary analysis may
show to what extent this effects the scores on outcome
measurements of the patients.
GP intervention
All patients will be treated by the GP according to their
clinical guideline (see Figure 3). GPs will give information
and advice about LRS. If necessary they prescribe adequate
pain medication. We asked the GPs not to refer patients to
paramedical specialists (i.e. manual therapist, physical
therapist, exercise therapist, etc.). Referral to PT is based
on randomisation and performed by the research
assistant.
PT intervention
PT treatment will imply information and advice about
LRS and exercise therapy. Passive modalities such as mas-
sage, manipulation techniques or applying applications
(e.g. ultra sound or current waves) are not allowed in the
PT treatment. This PT treatment protocol was accom-
plished in a consensus meeting with participating PTs.
The PT will report what kind of information/ advice and
what type of exercise the patient receives in each session.
Both GP and PT intervention will be restricted to a maxi-
mum of 9 treatments/ consultations in the first 6 weeks
after randomisation.
Theoretical background
In the Netherlands, PTs are mainly taught the bio-
mechanic model [13]. This model focuses on somatic
issues; it assumes a causal relation between tissue damage
and pain. PT could be of additional value in the manage-
ment of patients with LRS because PTs are 'the experts' in
treating musculoskeletal disorders with exercises and
advice/ information. The pain reported by a patient is
used as guidance to determine the intensity of the exer-
cises and the advice about resuming normal daily activi-
ties and work. This study assumes that focussing on (pain)
complaints with exercises and advice is the optimal PT
treatment in the acute phase (0 to 6 weeks) of LRS.
It is possible that patients may suffer from a fear of move-
ment because of pain [16]. Good advice/ information will
reassure these patients and exercises will show them that
movement is possible. So, the secondary treatment goal of
the PT is to decrease the possibly present fear of move-
ment in these patients.
Sample size
This trial attempts to enrol 182 patients with LRS, 91
patients in both treatment groups. This sample size is
regarded sufficient to detect a difference of 20% (with a α
of 0.05 and a power of 80%) in the primary outcome
(GPE) between the two treatment groups. A difference of
20% is considered to be clinically relevant [17].
Measurements
Figure 4 shows the outcome measures and the points of
time they are collected. At baseline we will collect patients
characteristics such as gender, date of birth, height and
body weight. In standardised history taking there will be
established whether patients are familiar with LRS in the
past, report more pain in the leg on coughing/ sneezing or
straining, on sitting, standing, walking and lying down,
and if patients report a decreased muscle strength and sen-
sory deficits in the leg. The physical examination consists
of the straight leg raising test, the crossed straight leg rais-
ing test, test of Bragard, finger-floor distance, standing on
toes and heels, knee tendon reflex, ankle tendon reflex,
strength of m. extensor hallicus longus, sensory tests
(touch, sharp and blunt) in the dermatomes L5/ S1 in the
feet.
Primary outcome measure
The primary outcome measure is the Global Perceived
Effect (GPE), measured on a 7 points scale ranging from 1
= completely recovered to 7 = vastly worsened. It is
regarded a clinical relevant outcome measure and is
regarded valid and responsive to measure the patients'
perceived benefit [18-20].
Secondary outcome measures
Pain severity of the leg and the back will be scored on a 11
points Visual Analogue Scale (VAS) ranging from 0 = no
pain to 10 = unbearable pain. Reliability, validity and
responsiveness of the VAS have been shown [21-23].
The functional status will be measured with the Roland
Morris Disability Questionnaire (RDQ) for sciatica [24].
The scoring of the RDQ is achieved by counting the
number of positive responses: a patient individual score
can vary from 0 (no disability) to 24 (severe disability).
The RDQ has proved to be a valid instrument and appears
to be responsive for clinical relevant changes [20,25-28].
Health status will be measured by the 36-item short form
(SF-36) [29] and the Euroqol (EQ-5D) instrument
[30,31]. Validity and responsiveness on both SF-36 [32-
34] and EQ-5D [35-37] proved to be sufficient.
Fear of movement will be measured by the Tampa scale
for kinesiophobia (TSK) [38,39]. The TSK consists of 17
items; each rated on a 4-point likert scale. The TSK has
been shown to be a valid and responsive instrument
[40,41].BMC Musculoskeletal Disorders 2004, 5:39 http://www.biomedcentral.com/1471-2474/5/39
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Summary of the clinical guideline 'Lumbosacral radicular syndrome' of the Dutch College of General Practitioners (1996) Figure 3
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Costs will be calculated and include LRS related sickness
absence from work, medical consumption (i.e.
medication use, additional therapies, visits to health care
providers), out-of-pocket expenses and paid help.
Patients' treatment preference will be evaluated at base-
line and at 4 follow-up measurements.
Statistical analysis
Baseline comparability will be investigated by descriptive
statistics to examine whether randomisation was success-
ful. If necessary, adjustments for baseline variables will be
performed in the analysis. Group differences and 95%
confidence intervals will be calculated for all outcome
measures. The statistical analysis will be performed
according tot the intention-to-treat principle, analysing
the patients in the treatment group to which they were
randomly allocated. Between group differences will be
calculated using the Student t-test for continuous varia-
bles or Chi-Square for dichotomous variables. In addition
a per-protocol analysis will be performed, analysing only
those patients with no serious protocol deviations. Com-
paring the results of the intention-to-treat and the per-
Data collection and outcome measures Figure 4
Data collection and outcome measures.BMC Musculoskeletal Disorders 2004, 5:39 http://www.biomedcentral.com/1471-2474/5/39
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protocol analysis will indicate if and to what extent proto-
col deviations might have biased the results. Multivariate
regression analysis will be conducted to examine the
influence of baseline variables on outcome.
Discussion
This article introduces a design of a RCT to evaluate the
additional effectiveness of PTs management added to GPs
management in patients with LRS. The study is designed
in a way that GP and PT treatment is transparent (accord-
ing a guideline and a consensus meeting) and not a com-
plete "black box". The results of this trial will contribute
to the decision of the GP regarding referral of patients
with LRS to PT. The inclusion of patients will run until the
end of the year 2004. The follow-up measurements will be
completed in the end of the year 2005.
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